Free Trial!
Today’s Best Stocks To Trade! Click Here
BearingPoint Inc. (NYSE: BE | Quote | Chart | News | PowerRating) provides management and technology consulting services primarily in North America and internationally. The company offers management consulting, technology solutions, application services, and managed services. Its integration services comprise designing, building, and implementing new or enhanced system applications and related processes; general business consulting services include system selection or assessment, feasibility studies, business valuations, and corporate strategy; and managed services consist of managing, staffing, maintaining, hosting, or otherwise running solutions and systems provided to its customers. The company serves agencies of the U.S. federal government, such as the departments of defense, homeland security, and health and human services; provincial, state, and local governments; public healthcare companies and private sector healthcare agencies; aerospace and defense companies; and higher education clients, as well as various sectors, including technology, consumer markets, manufacturing, life sciences, energy markets, transportation, communications, and private and public utilities. BearingPoint also provides solutions to banking, insurance, securities, real estate, hospitality, and professional services institutions. The company was founded in 1999. It was formerly known as KPMG Consulting, Inc. and changed its name to BearingPoint, Inc. in 2002. The company is headquartered in McLean, Virginia. With 217.9 million shares outstanding and 31.13 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of BE. According to quarterly data provided by the SEC, there were still 169,401 shares of BE that were failing-to-deliver as of September 13, 2007.
American Defense Systems Inc (AMEX: EAG | Quote | Chart | News | PowerRating) provides customized transparent and opaque armor solutions for tactical and non-tactical transport vehicles and construction equipment used by the military in the United States. It engages in the research and development, design and engineering, fabrication, and component integration; and provides subject matter experts in engineering, ballistics, government contracts, program management, and logistics. The company's products include crew protection kits for armor protection of operator compartments; VistaSteel transparent armor that provides a defensive barrier to protect against firearms, physical attack, and explosive blasts; VistaSteel opaque armor installed on various military vehicles to form up-armor or add-on armor kits; VistaGuard windows, which are forced entry blast resistant windows, window frames, and transparent armor assemblies used to mitigate forced entry, ballistic, and terrorist threats; forced entry blast resistant curtain wall; mobile ballistic shield, a bullet-resistant transparent mobile shield used in hostage negotiation and other hostile situations; and trans-barrier system, a transparent armor shield to provide ballistic and blast protection. ADSI also offers heated ballistic ships' windows; proprietary hardware, including hinges, rotary and slam latch, combat lock, and egress window; T2 ballistic range, a live fire interactive training range system to provide training to war fighters or law enforcement personnel; handheld, lightweight police shields; and lightweight combat helmet with ballistic resistance. The company serves military, government, law enforcement, detention and security industry, and correctional agencies, as well as private sector. It also operates a retail outlet carrying body armor, tactical nylon products, weapons, ammunition, weapons parts and accessories, and other tactical gear. American Defense Systems, Inc. was founded in 1994 and is headquartered in Hicksville, New York. With 39.34 million shares outstanding and 17,200 shares declared short as of July 2008, there is no longer a failure to deliver in shares of EAG.
New Gold Inc (AMEX: NGD | Quote | Chart | News | PowerRating) engages in the acquisition and mining of mineral properties. It primarily focuses on gold, copper, and silver deposits. The company's assets portfolio is located in Canada, Chile, Mexico, Brazil, Australia, and Alaska. New Gold, Inc. is based in Vancouver, Canada. With 36.95 million shares outstanding and 3.75 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of NGD. According to quarterly data provided by the SEC, there were still 28,032 shares of NGD that were failing-to-deliver as of August 22, 2007.
Accentia Biopharmaceuticals Inc. (NASDAQ: ABPI | Quote | Chart | News | PowerRating) a biopharmaceutical company, together with its subsidiaries, develops and commercializes drug candidates that are in late-stage clinical development based on active pharmaceutical ingredients in the therapeutic areas of respiratory disease and oncology. It operates in two segments: Biopharmaceutical Products and Services, and Specialty Pharmaceuticals. The Biopharmaceutical Products and Services segment develops late-stage biopharmaceutical products. Its products, which are under Phase III clinical trials, include SinuNase for the treatment of chronic rhinosinusitis; BiovaxID, a patient-specific anti-cancer vaccine focusing on the treatment of follicular non-Hodgkins lymphoma; and Revimmune for the treatment of multiple sclerosis, an autoimmune disease that affects the central nervous system, and various autoimmune diseases, including systemic lupus, myasthenia gravis, and aplastic anemia. This segment also provides various consulting services relating to biopharmaceutical product development; and engages in the production of custom biologic products and cell culture instruments and systems for biopharmaceutical and biotechnology companies, medical schools, universities, hospitals, and research institutions. The Specialty Pharmaceuticals segment markets and sells pharmaceutical products that are developed primarily by third-party development partners. Its products comprise Respi-TANN, a prescription antitussive decongestant for temporary relief of cough and nasal congestion; SinuTest, a test used in connection with the diagnosis of chronic sinusitis; and Zinotic, a treatment of superficial infections of the external ear. This segment's products under development include AllerNase, a formulated suspension of an intranasal topical steroid indicated for the treatment of allergic and non-allergic rhinitis; and Emezine, a product for control of nausea and vomiting. The company was founded in 2002 and is headquartered in Tampa, Florida. With 45.23 million shares outstanding and 2 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of ABPI. According to quarterly data provided by the SEC, there were still 121,208 shares of ABPI that were failing-to-deliver as of September 28, 2007.
ev3 Inc. (NASDAQ: EVVV | Quote | Chart | News | PowerRating) a medical device company, focuses on catheter-based technologies for the endovascular treatment of vascular diseases and disorders. It develops, manufactures, and markets a range of products that include stents, atherectomy and thrombectomy products, balloon angioplasty catheters, microcatheters and occlusion balloon systems, embolic protection devices, infusion catheters/wires, embolic coils, and liquid embolics. The company markets its products in the United States, Europe, and Canada through a direct sales force, and through distributors in the United States and international markets. ev3, Inc. has a research collaboration with Merck & Co., Inc. for the analysis of atherosclerotic plaque removed from patient arteries with the goal of identifying new biomarkers of atherosclerotic disease progression and new therapies for atherosclerotic disease. The company is headquartered in Plymouth, Minnesota. With 105.22 million shares outstanding and 10.73 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of EVVV. According to quarterly data provided by the SEC, there were still 31,556 shares of EVVV that were failing-to-deliver as of September 27, 2007.
Gladstone Investment Corp. (NASDAQ: GAIN | Quote | Chart | News | PowerRating) is a public investment firm specializing in buyouts and recapitalizations. It seeks to make debt and equity investments in small and mid-sized private businesses. The firm invests in junior subordinated loans, mezzanine debt, preferred stock, and warrants to purchase common stock of U.S. based companies. It can also invest in senior secured loans and common stock. The firm prefers to invest between $3 million and $20 million. It invests individually as well as jointly with other buyout funds. The firm is treated as a business development company under the 1940 Act. Gladstone Management Corporation serves as the investment adviser of the firm. It was founded in February 2005 and is based in McLean, Virginia. Gladstone Investment Corporation operates as a subsidiary of The Gladstone Companies. With 16.56 million shares outstanding and 127,500 shares declared short as of July 2008, there is no longer a failure to deliver in shares of GAIN. According to quarterly data provided by the SEC, there were still 10,596 shares of GAIN that were failing-to-deliver as of August 8, 2007.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,050,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
